Literature DB >> 26292909

Antiepileptic drug withdrawal in medically and surgically treated patients: a meta-analysis of seizure recurrence and systematic review of its predictors.

Herm J Lamberink1, Willem M Otte2, Karin Geleijns1, Kees P J Braun1.   

Abstract

AIM: Many seizure-free patients consider withdrawal of antiepileptic drugs, both when seizure control is achieved by medication alone, or once they became seizure-free following epilepsy surgery. The risk of recurrence is consequently of very important prognostic value. However, estimations of recurrence risks are outdated for both populations. In addition, although many publications have reported predictors of seizure relapse, no comprehensive overview of prognostic factors is available.
METHODS: A systematic review of the databases of PubMed and EMBASE was conducted, identifying articles on antiepileptic drug withdrawal in patient cohorts. Recurrence risk meta-analyses were performed for both populations at one, two, three to four, and five or more years of follow-up. Within the selected articles, studies presenting multivariable analysis of predictors were identified; all studied predictors were listed, as well as all significant independent predictors. The quality of separate analyses of predictors was assessed.
RESULTS: There was no significant difference of long-term cumulative recurrence risk between surgical and medication-only populations, with respectively 29% and 34% recurrences. In medication-only treated patients, 25 factors have been reported as significant independent predictors; 12 have been reported in surgical cohorts. The quality of most analyses of predictors was low to moderate. No predictor was consistently found among all analyses, and for most predictors, study results were contradictory.
CONCLUSION: No consistent set of predictors could be identified because a large number of variables have been identified in the literature, many studies reported contradicting results, study populations varied considerably, and the quality of the original studies was often low. Meta-analysis of individual participant data is necessary, because it allows for (1) correction for differences in follow-up duration between subjects and studies, (2) a study of interaction effects, (3) calculation of more accurate estimates valid across several populations, and (4) the assessment of each predictor's effect size.

Entities:  

Keywords:  AED withdrawal; meta-analysis; predictors; recurrence; systematic review

Mesh:

Substances:

Year:  2015        PMID: 26292909     DOI: 10.1684/epd.2015.0764

Source DB:  PubMed          Journal:  Epileptic Disord        ISSN: 1294-9361            Impact factor:   1.819


  8 in total

1.  Deciding When Less Is More: The Crossroads of Withdrawing Antiepileptic Drugs.

Authors:  Naymee Velez Ruiz
Journal:  Epilepsy Curr       Date:  2018 Jan-Feb       Impact factor: 7.500

2.  Brain functional and structural characteristics of patients with seizure recurrence following drug withdrawal.

Authors:  Ge Tan; Xiuli Li; Deng Chen; Haijiao Wang; Qiyong Gong; Ling Liu
Journal:  Neuroradiology       Date:  2021-07-01       Impact factor: 2.804

3.  Real life pharmaceutical treatment patterns for adult patients with focal epilepsy in Germany: a longitudinal and cross-sectional analysis of recently approved anti-epileptic drugs.

Authors:  Antje Groth; Thomas Wilke; Simon Borghs; Patrick Gille; Lars Joeres
Journal:  Ger Med Sci       Date:  2017-06-12

4.  Knowledge, attitude, and beliefs on epilepsy among adults in Erute South, Lira District, Uganda.

Authors:  Frank Kiwanuka; Carolyne Anyango Olyet
Journal:  Epilepsia Open       Date:  2018-05-13

5.  Reappraisal of the Medical Research Council Antiepileptic Drug Withdrawal Study: Contamination-adjusted and dose-response re-analysis.

Authors:  Samuel W Terman; Chang Wang; Lu Wang; Kees P J Braun; Willem M Otte; Geertruida Slinger; Wesley T Kerr; Morten I Lossius; Laura Bonnett; James F Burke; Anthony Marson
Journal:  Epilepsia       Date:  2022-05-18       Impact factor: 6.740

6.  Incidence of and predictors for antiseizure medication gaps in Medicare beneficiaries with epilepsy: a retrospective cohort study.

Authors:  Samuel W Terman; Joshua D Niznik; Geertruida Slinger; Willem M Otte; Kees P J Braun; Carole E Aubert; Wesley T Kerr; Cynthia M Boyd; James F Burke
Journal:  BMC Neurol       Date:  2022-09-01       Impact factor: 2.903

7.  Refractory juvenile myoclonic epilepsy: a meta-analysis of prevalence and risk factors.

Authors:  R Stevelink; B P C Koeleman; J W Sander; F E Jansen; K P J Braun
Journal:  Eur J Neurol       Date:  2018-10-07       Impact factor: 6.089

8.  Prediction of seizure recurrence risk following discontinuation of antiepileptic drugs.

Authors:  Margherita Contento; Bruno Bertaccini; Martina Biggi; Matteo Magliani; Ylenia Failli; Eleonora Rosati; Luca Massacesi; Marco Paganini
Journal:  Epilepsia       Date:  2021-07-12       Impact factor: 5.864

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.